Biovail Pharma to Pay Nearly $25M in Kickbacks Case

Tue, 09/15/2009 - 4:53am
BOSTON (AP) — A New Jersey pharmaceuticals firm will pay nearly $25 million in criminal and civil fines after pleading guilty to federal charges that it made illegal payments to encourage doctors to prescribe a blood pressure drug. The U.S. attorney's office in Boston announced Monday that Massachusetts-based Biovail Pharmaceuticals Inc. was sentenced to pay $22.2 million after pleading guilty to conspiracy and kickback charges. The company also will pay a $2.4 million civil penalty. Prosecutors alleged Biovail paid thousands of physicians and others up to $1,000 apiece to induce them to prescribe or recommend Cardizem LA. The company is a subsidiary of Toronto-based Biovail Corp., which announced in May 2008 it had agreed to plead guilty and pay to settle the case.

Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.